NeuroBo Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 44.4%.

Top 21 shareholders own 9.77% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
3.11%	Goldman Sachs Group, Investment Banking and Securities Investments	152,563	US$466.8k	0%	no data
3.06%	Strategic Risk, Llc.	150,354	US$460.1k	0%	no data
0.85%	Hudson Bay Capital Management LP	41,666	US$127.5k	0%	no data
0.74%	Next Edge Capital Corp.	36,198	US$110.8k	0%	0.41%
0.51%	E&Investment, Inc.	25,069	US$76.7k	0%	2.13%
0.35%	Geode Capital Management, LLC	17,332	US$53.0k	-0.01%	no data
0.24%	Dong-A ST Co., Ltd.	12,003	US$36.7k	0%	no data
0.18%	The Vanguard Group, Inc.	8,698	US$26.6k	0%	no data
0.12%	Na-Yeon Kim	5,651	US$17.3k	0%	no data
0.11%	D. Strickland	5,469	US$16.7k	0%	no data
0.11%	Jason Groves	5,469	US$16.7k	0%	no data
0.11%	Andrew Koven	5,469	US$16.7k	0%	no data
0.11%	Michael Salsbury	5,469	US$16.7k	0%	no data
0.11%	BlackRock, Inc.	5,274	US$16.1k	0%	no data
0.044%	Tower Research Capital LLC	2,159	US$6.6k	39.9%	no data
0.012%	Dimensional Fund Advisors LP	576	US$1.8k	0.35%	no data
0.0017%	Hyung-Heon Kim	83	US$253.7	0%	no data
0.00051%	Morgan Stanley, Investment Banking and Brokerage Investments	25	US$76.6	2,400%	no data
0.00051%	Wells Fargo & Company, Private Banking and Investment Banking Arm	25	US$76.6	8.7%	no data
0.00004%	Comerica Bank, Banking Investments	2	US$6.0	0%	no data
0.00002%	Merrill Lynch & Co. Inc., Banking Investments	1	US$3.0	0%	no data